Published in Blood Weekly, December 20th, 2001
"Intensive chemotherapy (CHT) in AIDS-related non-Hodgkin's lymphoma (AIDS-NHL patients) is a vexing problem," according to Dr. Roberta Gastaldi and colleagues at University La Sapienza in Rome.
Gastaldi and coauthors say that a regimen based on high-doses of idarubicin produced positive results in their preliminary study.
The researchers evaluated the safety and efficacy of this drug regimen in 14 treatment-naive patients with diffuse large cell AIDS-NHL. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.